ENTRESTO ® is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction. ENTRESTO is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic...
Entresto ® is reimbursed for the treatment of adult patients with chronic heart failure with reduced ejection fraction in Belgium.
Early breast cancer
Kisqali® in combination with an aromatase inhibitor is indicated for the adjuvant treatment of patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative early...
Kisqali ® is reimbursed in Belgium, you can find the reimbursement conditions on the INAMI website .
E-HealthYou can request reimbursement by...